These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 28704339

  • 1. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas.
    Moreau A, Giraudet AL, Kryza D, Borson-Chazot F, Bournaud C, Mognetti T, Lifante JC, Combemale P, Giammarile F, Houzard C.
    Nucl Med Commun; 2017 Sep; 38(9):771-779. PubMed ID: 28704339
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. FDOPA Patterns in Adrenal Glands: A Pictorial Essay.
    Moreau A, Giraudet AL, Kryza D, Borson-Chazot F, Bournaud-Salinas C, Mognetti T, Lifante JC, Combemale P, Giammarile F, Houzard C.
    Clin Nucl Med; 2017 May; 42(5):379-382. PubMed ID: 28319498
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quantitative 18F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype.
    Amodru V, Guerin C, Delcourt S, Romanet P, Loundou A, Viana B, Brue T, Castinetti F, Sebag F, Pacak K, Taïeb D.
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):278-282. PubMed ID: 28918451
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of adrenal masses using 18 F-FDOPA PET/CT in patients suspected with pheochromocytoma.
    Kim SJ, Park CY, Kwon H, Kim YH.
    Nucl Med Commun; 2024 Jan 01; 45(1):86-92. PubMed ID: 37901929
    [Abstract] [Full Text] [Related]

  • 8. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using 68Ga-DOTATATE, FDG, 18F-FDOPA, and 18F-FDA).
    Jha A, Patel M, Carrasquillo JA, Ling A, Millo C, Saboury B, Chen CC, Wakim P, Gonzales MK, Meuter L, Knue M, Talvacchio S, Herscovitch P, Rivero JD, Chen AP, Nilubol N, Taïeb D, Lin FI, Civelek AC, Pacak K.
    AJR Am J Roentgenol; 2022 Feb 01; 218(2):342-350. PubMed ID: 34431366
    [Abstract] [Full Text] [Related]

  • 9. The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.
    Timmers HJ, Hadi M, Carrasquillo JA, Chen CC, Martiniova L, Whatley M, Ling A, Eisenhofer G, Adams KT, Pacak K.
    J Nucl Med; 2007 Oct 01; 48(10):1599-606. PubMed ID: 17873132
    [Abstract] [Full Text] [Related]

  • 10. (18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.
    Magnaldi S, Mayerhoefer ME, Khameneh A, Schuetz M, Javor D, Mitterhauser M, Dudczak R, Hacker M, Karanikas G.
    Anticancer Res; 2014 Feb 01; 34(2):791-5. PubMed ID: 24511014
    [Abstract] [Full Text] [Related]

  • 11. 18F-FDOPA PET/CT Uptake Parameters Correlate with Catecholamine Secretion in Human Pheochromocytomas.
    Moog S, Houy S, Chevalier E, Ory S, Weryha G, Rame M, Klein M, Brunaud L, Gasman S, Cuny T.
    Neuroendocrinology; 2018 Feb 01; 107(3):228-236. PubMed ID: 29949805
    [Abstract] [Full Text] [Related]

  • 12. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
    Archier A, Varoquaux A, Garrigue P, Montava M, Guerin C, Gabriel S, Beschmout E, Morange I, Fakhry N, Castinetti F, Sebag F, Barlier A, Loundou A, Guillet B, Pacak K, Taïeb D.
    Eur J Nucl Med Mol Imaging; 2016 Jul 01; 43(7):1248-57. PubMed ID: 26637204
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
    Fueger BJ, Czernin J, Cloughesy T, Silverman DH, Geist CL, Walter MA, Schiepers C, Nghiemphu P, Lai A, Phelps ME, Chen W.
    J Nucl Med; 2010 Oct 01; 51(10):1532-8. PubMed ID: 20847166
    [Abstract] [Full Text] [Related]

  • 15. False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors.
    Berends AMA, Kerstens MN, Bolt JW, Links TP, Korpershoek E, de Krijger RR, Walenkamp AME, Noordzij W, van Etten B, Kats-Ugurlu G, Brouwers AH, van der Horst-Schrivers ANA.
    Eur J Endocrinol; 2018 Aug 01; 179(2):125-133. PubMed ID: 29875288
    [Abstract] [Full Text] [Related]

  • 16. 18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
    Lugat A, Drui D, Mirallié E, Kraeber-Bodéré F, Ansquer C.
    Clin Nucl Med; 2019 Sep 01; 44(9):738-740. PubMed ID: 31306205
    [Abstract] [Full Text] [Related]

  • 17. Identify glioma recurrence and treatment effects with triple-tracer PET/CT.
    Li C, Yi C, Chen Y, Xi S, Guo C, Yang Q, Wang J, Sai K, Zhang J, Ke C, Chen F, Lv Y, Zhang X, Chen Z.
    BMC Med Imaging; 2021 May 31; 21(1):92. PubMed ID: 34059015
    [Abstract] [Full Text] [Related]

  • 18. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
    Rischke HC, Benz MR, Wild D, Mix M, Dumont RA, Campbell D, Seufert J, Wiech T, Rössler J, Weber WA, Neumann HP.
    J Nucl Med; 2012 Sep 31; 53(9):1352-8. PubMed ID: 22836345
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bilateral Adrenal Extremely Intense Metabolic Activity on 18F-FDG PET/CT in a Patient With Pheochromocytomas.
    Chen X, Chen G, Fu Z, Li Q.
    Clin Nucl Med; 2019 Sep 31; 44(9):748-749. PubMed ID: 31107752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.